What are the etiologies of generalized mechanical allodynia and what is the appropriate workup?

Generalized Mechanical Allodynia: Etiologies and Workup

Generalized mechanical allodynia most commonly results from small fiber sensory polyneuropathy (SFSN), central sensitization syndromes like fibromyalgia, or distal symmetric polyneuropathy (DSP) with small fiber involvement—and the workup should begin with nerve conduction studies, followed by skin biopsy for intraepidermal nerve fiber density if NCS is normal, plus targeted laboratory testing based on clinical phenotype.

Primary Etiologies

Peripheral Neuropathic Causes

Small Fiber Sensory Polyneuropathy (SFSN) is a leading cause, manifesting as burning pain with allodynia, often with concurrent autonomic and somatic C-fiber involvement 1. This phenotype typically presents with:

• Burning pain affecting distal extremities
• Mechanical allodynia (pain from light touch)
• Sometimes erythromelalgia (red, hot, painful skin)
• Preserved reflexes and normal nerve conduction studies initially

Distal Symmetric Polyneuropathy (DSP) can present with generalized allodynia when small fibers are affected alongside large fiber involvement 1. Look for:

• Decreased or absent ankle reflexes
• Decreased distal sensation
• Distal muscle weakness or atrophy
• Abnormal nerve conduction studies

Central Sensitization

Fibromyalgia represents generalized mechanical allodynia from central nervous system hyperexcitability rather than peripheral nerve damage 2. A simple bedside test is sphygmomanometry-evoked allodynia: inflating a blood pressure cuff to 180 mmHg (or until pain occurs) elicits pain at lower pressures in fibromyalgia patients (mean 143 mmHg) versus controls (176 mmHg), with 69% sensitivity and 96% specificity 2.

Pathophysiological Mechanisms

Multiple mechanisms can operate simultaneously 3:

• Peripheral sensitization: Pathologically active or sensitized nociceptors inducing spinal cord hyperexcitability, causing Aβ-fiber input (light touch) to be perceived as pain
• Anatomic reorganization: C-fiber degeneration leading to dorsal horn reorganization and Aβ-fiber-mediated allodynia
• Inflammatory nerve reactions: Persistent inflammation inducing ectopic nociceptor activity
• Sympathetic coupling: Sympathetically maintained pain via noradrenaline-receptor interactions

Diagnostic Workup Algorithm

Step 1: Clinical Phenotyping

Determine the pattern of sensory involvement:

• Distal symmetric pattern: Suggests length-dependent polyneuropathy
• Generalized/widespread pattern: Consider fibromyalgia or central sensitization
• Patchy/multifocal: Consider mononeuropathy multiplex or vasculitic neuropathy

Assess for autonomic symptoms:

• Abnormal sweating patterns
• Circulatory instability in feet
• Orthostatic symptoms

Step 2: Electrodiagnostic Testing

Nerve conduction studies (NCS) are essential as they detect large fiber involvement with high sensitivity and specificity, and distinguish demyelinating from axonal patterns 1, 4.

Critical caveat: NCS may be normal in pure small fiber neuropathy, as these studies primarily assess large myelinated fibers 1.

Step 3: Small Fiber Assessment (if NCS normal or non-diagnostic)

Skin biopsy for intraepidermal nerve fiber (IENF) density is validated and recommended for diagnosing SFSN when clinical suspicion is high 1. This is a Level C recommendation from the American Academy of Neurology guidelines.

Autonomic testing may be considered, particularly:

• Heart rate variability testing (detects diabetic polyneuropathy with sensitivity nearly equal to NCS) 1
• Quantitative sudomotor axon reflex testing (QSART)
• Cardiovagal function assessment

Step 4: Laboratory Evaluation

Target testing based on clinical phenotype rather than shotgun screening 4:

For length-dependent polyneuropathy pattern:

• Fasting glucose and HbA1c (diabetes is most common cause)
• Vitamin B12 with methylmalonic acid
• Thyroid function
• Serum protein electrophoresis with immunofixation
• Consider: HIV, hepatitis C, ANA, rheumatoid factor

For suspected hereditary neuropathy (slowly progressive, family history, pes cavus, hammer toes):

• Genetic testing guided by phenotype (demyelinating vs. axonal on NCS)
• CMT1A duplication/deletion and Cx32 mutations have highest yield 4

For suspected inflammatory/immune causes:

• Anti-ganglioside antibodies
• Paraneoplastic panel if subacute onset

Step 5: Consider Genetic Testing in Select Cases

Genetic variants in voltage-gated sodium channels (SCN9A, SCN10A) may cause altered pain perception, though variants of unknown significance are common and functional significance often unclear 5. Reserve genetic testing for:

• Pediatric cases with unexplained neuropathic pain
• Classical hereditary neuropathy phenotype
• Family history suggesting genetic etiology

Common Pitfalls to Avoid

1. Don't assume normal NCS excludes neuropathy: Small fiber neuropathy requires skin biopsy or autonomic testing for diagnosis 1.

2. Don't overlook fibromyalgia: Test for sphygmomanometry-evoked allodynia as a simple screening tool 2.

3. Don't order indiscriminate genetic panels: Yield is low without classical hereditary phenotype; target testing based on clinical features 4.

4. Don't miss central mechanisms: Dynamic mechanical allodynia with "windup" (increasing pain with repetitive stimulation) suggests peripheral neuropathic pain, while absence suggests central pain 6.

5. Recognize that mechanisms evolve: The pain-generating mechanism and symptoms may change during disease course, requiring reassessment 3.